SCHEMBL7315167

SCHEMBL7315167

CS(=O)(=O)NC1(c2ccccc2)CCN(Cc2ccccc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 1/20 0.52
POLB P06746 1/20 0.51
TACR3 P29371 1/20 0.50
CYP2D6 P10635 6/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
OPRM1 P35372 1/20 0.49
CYP3A4 P08684 3/20 0.48
HSD17B10 Q99714 1/20 0.48
MC4R P32245 1/20 0.47
TSHR P16473 2/20 0.47
SIGMAR1 Q99720 1/20 0.46
ALDH1A1 P00352 2/20 0.45
DPP4 P27487 1/20 0.45
CCR3 P51677 1/20 0.45
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
HIF1A Q16665 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7750655 0.89 ALDH1A1 (0.47) OPRL1POLBTACR3CYP2D6MEN1
SCHEMBL16420398 0.82 POLB (0.47) POLBTACR3OPRM1TSHRALDH1A1
SCHEMBL4630049 0.81 OPRL1 (0.59) OPRL1POLBCYP2D6MEN1KMT2A
SCHEMBL7306255 0.80 OPRL1 (0.58) OPRL1POLBCYP2D6MEN1KMT2A
SCHEMBL6887496 0.80 CYP2D6 (0.48) OPRL1POLBCYP2D6MEN1KMT2A
SCHEMBL4631243 0.78 POLB (0.64) OPRL1POLBTACR3CYP2D6OPRM1
SCHEMBL4631769 0.77 OPRL1 (0.55) OPRL1POLBCYP2D6MEN1KMT2A
SCHEMBL16418422 0.77 OPRM1 (0.55) POLBTACR3OPRM1HSD17B10ALDH1A1
Formic Acid SCHEMBL6140137 0.77 OPRL1 (0.55) OPRL1POLBCYP2D6OPRM1CYP3A4
Hydrochloric Acid SCHEMBL9317938 0.77 POLB (0.62) OPRL1POLBTACR3CYP2D6HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965580-A TREATMENT OF SUBSTANCE P- AND NEUROKININ-DEPENDENT DISORDERS SANOFI (FR) 1999-10-12 US disclosed
US-5939411-A PIPERIDINE DERIVATIVES SUBSTITUTED AT POSITION 4 WITH NEW FUNCTIONS OTHER THAN THOSE DESCRIBED PREVIOUSLY HAVE A HIGH AFFINITY FOR NEUROKININ RECEPTORS AND ARE USEFUL FOR TREATMENT OF SUBSTANCE P AND NEUROKININ DEPENDENT PATHOLOGIES SANOFI (FR) 1999-08-17 US disclosed
US-5830906-A Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them SANOFI (FR) 1998-11-03 US disclosed
EP-0673928-A1 Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists SANOFI (FR) 1995-09-27 EP disclosed